COMP <GO>
HCM vs PBH // EV/EBITDA & P/E VALUATION
HUTCHMED (China) Limited (NASDAQ) VS. Prestige Consumer Healthcare Inc. (NYSE) • 15-METRIC TALLY: HCM 4
— PBH 6
■ METRIC PARITY
LAST: $13.59 (+2.03%) • MKT CAP: $2.37B
valuation
—
LAST: $48.75 (+2.01%) • MKT CAP: $2.31B
valuation
7.0x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HCM VS. PBH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HCM | PBH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 54.70% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -2.50% | 13.80% | -16.30 | PBH | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | 7.0x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -3.32% | 10.67% | -13.99 | PBH | /fcf-yield <GO> |
| Operating Margin | -7.10% | 28.40% | -35.50 | PBH | /operating-margins <GO> |
| Net Profit Margin | 68.00% | 17.50% | +50.50 | HCM | /net-margins <GO> |
| Revenue Growth (YoY) | -13.00% | -4.30% | -8.70 | PBH | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.63 | 2.21 | +1.42 | HCM | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 6/9 | -2.00 | PBH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 54.1 | -13.07 | PBH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 4.8x | 11.3x | -6.50 | HCM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.37B | $2.31B | $61.5M | HCM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HCM REV | PBH REV | HCM GROSS % | PBH GROSS % | HCM FCF | PBH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $548.5M | $1.09B | 38.7% | 54.7% | -$78.8M | $246.4M |
| FY 2024 | $630.2M | $1.14B | 44.6% | 55.8% | -$17.4M | $243.3M |
| FY 2023 | $838.0M | $1.13B | — | — | $219.3M | $248.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HCM // BETA —
PBH // BETA —